Bioscience Equity Partners
Investment banking and venture capital group focused on early-stage life sciences. Provides equity funding, fund management and bespoke investment banking services to biotech, medtech and digital health companies, with global offices and strategic partnerships to support commercialization and growth.
Industries
Nr. of Employees
small (1-50)
Bioscience Equity Partners
Sydney, New South Wales, Australia, Oceania
Services
Equity investments and venture capital deployment for early-stage life-science companies.
Advisory services for capital raises, M&A, and strategic transactions in life sciences.
Management of venture funds and investment vehicles focused on bioscience opportunities.
Structured assessments of market potential, team, business model and funding readiness to determine investability.
Services to develop investor outreach strategies, pitch materials and matchmaking with potential investors and partners.
Connecting companies to regional markets, governmental agencies and industry partners through international offices and alliances.
Equity investments and venture capital deployment for early-stage life-science companies.
Advisory services for capital raises, M&A, and strategic transactions in life sciences.
Management of venture funds and investment vehicles focused on bioscience opportunities.
Structured assessments of market potential, team, business model and funding readiness to determine investability.
Services to develop investor outreach strategies, pitch materials and matchmaking with potential investors and partners.
Connecting companies to regional markets, governmental agencies and industry partners through international offices and alliances.
Expertise Areas
- Venture capital and early-stage funding
- Investment banking and M&A advisory for life sciences
- Fund management
- Global market access and strategic partnerships
Key Technologies
- Gene therapy
- Immunotherapy
- Drug development
- Medical devices and diagnostics
News & Updates
Attended and partnered at BIO KOREA 2022 to engage in international biohealth business development and partnering.
Engaged at Digital RESI conference focused on early-stage investments across drugs, devices, diagnostics and digital health.
Connected with partners and potential licensees through the BIOTECHGATE virtual partnering event.
Attended RESI Boston conference to meet investors and corporate partners for early-stage ventures.
Feature interview with the founder/CEO discussing mission, strategy and focus areas including gene therapy, AI diagnostics and personalized medicine.
Awarded 'Best Life Science Investment Company in the US for the Year 2023' by Global Health & Pharma Magazine.
Attended and partnered at BIO KOREA 2022 to engage in international biohealth business development and partnering.
Engaged at Digital RESI conference focused on early-stage investments across drugs, devices, diagnostics and digital health.
Connected with partners and potential licensees through the BIOTECHGATE virtual partnering event.
Attended RESI Boston conference to meet investors and corporate partners for early-stage ventures.
Feature interview with the founder/CEO discussing mission, strategy and focus areas including gene therapy, AI diagnostics and personalized medicine.
Awarded 'Best Life Science Investment Company in the US for the Year 2023' by Global Health & Pharma Magazine.